In this study by utilizing multiplexed protein staining and gene expression analysis from clinical datasets we show that a significant number of breast cancer patients harbor high levels of P16INK4A protein in conjunction with cyclin E1. The gene discussed is CDKN2A; the disease is breast carcinoma.